Related Experiment Videos
Growth regulation and transformation of ovarian epithelium
A Berchuck1, M F Kohler, M P Boente
1Department of Obstetrics and Gynecology, Duke Comprehensive Cancer Center, Durham, North Carolina.
Abstract:
The discovery of peptide growth factors and cancer-causing genes (oncogenes and tumor-suppressor genes) has provided us with the exciting opportunity to begin to understand the molecular pathology of human ovarian cancer. Activation of several genes, including HER-2/neu, myc, ras, and p53 have been described in some ovarian cancers. In addition, some protooncogenes such as the epidermal growth factor receptor (erbB) and the M-CSF receptor (fms) are expressed along with the respective ligands (peptide growth factors) in some ovarian cancers. Although the studies reviewed in this paper represent a promising beginning, we remain far from a comprehensive understanding of growth regulation and transformation of human ovarian epithelium.
Insights
Researchers are exploring molecular changes in ovarian cancer, including oncogenes and growth factors. While progress is being made, a full understanding of ovarian cancer development remains elusive.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Human ovarian cancer molecular pathology is being investigated.
- Key genes like HER-2/neu, myc, ras, and p53 are implicated in some ovarian cancers.
- Protooncogenes and their ligands are expressed in certain ovarian cancers.
Purpose of the Study:
- To review the current understanding of molecular alterations in human ovarian cancer.
- To highlight the role of peptide growth factors and oncogenes in ovarian cancer development.
Main Methods:
- Review of existing studies on gene activation and expression in ovarian cancer.
- Analysis of protooncogene and peptide growth factor expression patterns.
Main Results:
- Activation of specific genes (HER-2/neu, myc, ras, p53) observed in some ovarian cancers.
- Co-expression of protooncogenes (erbB, fms) and their ligands identified in certain cases.
Conclusions:
- The discovery of growth factors and oncogenes offers insights into ovarian cancer.
- Current research represents a promising start but a comprehensive understanding is still needed.